Literature DB >> 23744868

Bone cancer.

J Sybil Biermann1, Douglas R Adkins, Mark Agulnik, Robert S Benjamin, Brian Brigman, James E Butrynski, David Cheong, Warren Chow, William T Curry, Deborah A Frassica, Frank J Frassica, Kenneth R Hande, Francis J Hornicek, Robin L Jones, Joel Mayerson, Sean V McGarry, Brian McGrath, Carol D Morris, Richard J O'Donnell, R Lor Randall, Victor M Santana, Robert L Satcher, Herrick J Siegel, Margaret von Mehren, Mary Anne Bergman, Hema Sundar.   

Abstract

Primary bone cancers are extremely rare neoplasms, accounting for fewer than 0.2% of all cancers. The evaluation and treatment of patients with bone cancers requires a multidisciplinary team of physicians, including musculoskeletal, medical, and radiation oncologists, and surgeons and radiologists with demonstrated expertise in the management of these tumors. Long-term surveillance and follow-up are necessary for the management of treatment late effects related to surgery, radiation therapy, and chemotherapy. These guidelines discuss the management of chordoma, giant cell tumor of the bone, and osteosarcoma.

Entities:  

Mesh:

Year:  2013        PMID: 23744868     DOI: 10.6004/jnccn.2013.0088

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  38 in total

1.  CORR Insights®: how much tumor surgery do early-career orthopaedic oncologists perform?

Authors:  J Sybil Biermann
Journal:  Clin Orthop Relat Res       Date:  2014-10-25       Impact factor: 4.176

2.  Role of β-isomerized C-terminal telopeptides (β-CTx) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkers.

Authors:  Tu Hu; Qingcheng Yang; Jing Xu; Zhichang Zhang; Nengbin He; Yuzhen Du
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.

Authors:  Matthew D Cheney; Yen-Lin Chen; Ruth Lim; Barbara K Winrich; Anca L Grosu; Alexei V Trofimov; Nicolas Depauw; Helen A Shih; Joseph H Schwab; Francis J Hornicek; Thomas F DeLaney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

4.  circ-RANGAP1/MicroRNA-542-3p/Myosin Regulatory Light Chain Interacting Protein Axis Modulates the Osteosarcoma Cell Progression.

Authors:  Jundong Sheng; Jin Liu; Junwang Du; Yongping Wang
Journal:  Appl Bionics Biomech       Date:  2022-06-14       Impact factor: 1.664

5.  The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression.

Authors:  Nan Cai; Wei Zhou; Lan-Lan Ye; Jun Chen; Qiu-Ni Liang; Gang Chang; Jia-Jie Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  Isolated Avulsion Fracture of the Lesser Trochanter in Adults.

Authors:  Hwan Seong Cho; Young-Kyun Lee; Byung-Ho Yoon; Jung-Wee Park; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway.

Authors:  Yang Liu; Siting Yang; Feng Wang; Zheng Zhou; Wenjing Xu; Jingjing Xie; Linhui Qiao; Yanglin Gu
Journal:  Oncol Lett       Date:  2021-05-18       Impact factor: 2.967

Review 8.  Team Approach: Osteosarcoma of the Distal Part of the Femur in Adolescents.

Authors:  Russell N Stitzlein; John Wojcik; Ronnie A Sebro; Naomi J Balamuth; Kristy L Weber
Journal:  JBJS Rev       Date:  2017-12

Review 9.  The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework.

Authors:  Geoffrey W Siegel; J Sybil Biermann; Rashmi Chugh; Jon A Jacobson; David Lucas; Mary Feng; Andrew C Chang; Sean R Smith; Sandra L Wong; Jill Hasen
Journal:  J Multidiscip Healthc       Date:  2015-02-19

Review 10.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.